The Claim
The comparative effect of semaglutide versus liraglutide on diabetes risk in adults without prior diabetes or cardiovascular disease has not been established by randomized controlled trials.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
There is no high-quality clinical trial evidence comparing whether semaglutide or liraglutide affects the risk of developing diabetes in adults who do not have diabetes or heart disease.
See the scientific wording
The comparative effect of semaglutide versus liraglutide on diabetes risk in adults without prior diabetes or cardiovascular disease is not established by randomized controlled trials, making real-world observational studies the primary source of evidence for this comparison.
No direct biological comparison has been made between semaglutide and liraglutide in people without diabetes or heart disease because no study has randomly assigned people to one drug or the other and measured which one prevents diabetes more effectively.
What the research says
1 studyNo big randomized trial has directly compared these two diabetes-preventing drugs, so scientists are using real-world patient data instead — and this study is exactly that kind of real-world comparison.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.